This is a Phase 2 randomized, multicenter, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy of HT-0712 in improving memory and cognitive performance in subjects with Age-Associated Memory Impairment (AAMI)
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Enrollment
119
Unnamed facility
Sun City, Arizona, United States
Unnamed facility
Long Beach, California, United States
Unnamed facility
Santa Monica, California, United States
Cognitive Drug Research™ (CDR) Study Specific Test Battery
Time frame: Weekly over the course of 6-weeks
Paired Associated Learning and Memory Test
Time frame: Weekly over the course of 6-weeks
Subject Global Impression Scale of Cognition (SGI-Cog)
Time frame: Weekly over the course of 6-weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Unnamed facility
Denver, Colorado, United States
Unnamed facility
Atlantis, Florida, United States
Unnamed facility
Brooksville, Florida, United States
Unnamed facility
Tampa, Florida, United States
Unnamed facility
Marlton, New Jersey, United States
Unnamed facility
Princeton, New Jersey, United States
Unnamed facility
New York, New York, United States
...and 6 more locations